MedPath

Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy

Not Applicable
Recruiting
Conditions
Congenital Cataract
Interventions
Procedure: PCCC+A-Vit procedure
Procedure: PCCC procedure without A-vit
Registration Number
NCT05136209
Lead Sponsor
Sun Yat-sen University
Brief Summary

Selecting the appropriate surgical approach for congenital cataracts presents challenging for ophthalmologists. This prospective, randomized controlled study aims to compare the prognosis of posterior continuous curvilinear capsulorhexis (PCCC) with or without anterior vitrectomy (A-Vit) in treating congenital cataracts.

Detailed Description

Due to the particularity of children's eye structure, selecting the appropriate surgical approach for congenital cataracts presents challenging for ophthalmologists. The major concerned postoperative problem is the after-cataract formation. As a result, PCCC with A-Vit is usually performed to prevent the formation of secondary cataracts. However. Debate over the indication and surgical procedure still persists since A-Vit and excessive manipulations may interfere with the development of the eye and increase the risk of postoperative inflammation, unstable intraocular pressure, macular edema, retinal detachment and so on. Thus, it is necessary to evaluate the safety and effectiveness of PCCC without A-Vit in congenital cataract surgery.

In this randomized clinical trial, children with equal degree of congenital cataract in both eyes are enrolled. Patients receive cataract surgery on both eyes on the same day. For each patient, one eye is randomly assigned to undergo PCCC+A-Vit procedure, while the fellow eye is undergoing PCCC procedure without A-Vit. PCCC+A-Vit procedure includes anterior continuous curvilinear capsulorhexis (ACCC), irrigation/aspiration (I/A), PCCC, and A-Vit. Primary intraocular lens implantation (IOL) is performed in children older than age of two. Investigators then compare the incidence of visual axis opacity, uveitis, iris/pupil abnormality and intraocular pressure between two groups.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Children with bilateral congenital cataracts without other ocular abnormalities
  • Gestational age at birth >37 weeks
  • No more than 18 years old
  • Pupils could dilate normally pre-operation
  • Have signed a consent form
  • Can be followed
Exclusion Criteria
  • Intraocular pressure >21 mmHg
  • History of ocular trauma and intraocular surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PCCC+A-Vit procedurePCCC+A-Vit procedureProcedure/Surgery: PCCC+A-Vit procedure ACCC + I / A + PCCC + A-vit or ACCC + I / A +PCCC + IOL + A-vit
PCCC procedure without A-vitPCCC procedure without A-vitProcedure/Surgery: PCCC procedure without A-vit ACCC + I / A + PCCC or ACCC + I / A +PCCC + IOL
Primary Outcome Measures
NameTimeMethod
Number of participants with visual axis opacification5 years

Number of participants with visual axis opacification evaluated based on the retro-illumination.

Number of participants with uveitis and iris/pupil abnormality5 years

Number of participants with uveitis and iris/pupil abnormality evaluated based on the slip lamp examination.

IOP5 years

Intraocular pressure measured by the Tono-pen or non-contact tonometer

Secondary Outcome Measures
NameTimeMethod
CCT change5 years

Change from baseline in the central corneal thickness (CCT) measured by pentacam.

AL change5 years

Change from baseline in axial length measured by AL-Scan, IOLMaster or A-scan

BCVA change5 years

Change from baseline in the best corrected visual acuity (BCVA) measured by the Teller's acuity card, the Lea symbol visual acuity chart or the ETDRS chart according the patient's age.

CFT change5 years

Change from baseline in the central foveal thickness (CFT) measured by Optical Coherence Tomography (OCT)

Trial Locations

Locations (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath